Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Migraine: Keeping the Beast at Bay
Do you know what drugs current guidelines recommend? Get an 8-slide update, here.
About 38% of migraineurs need preventive therapy, but only about 3% to 13% currently use it, according to the American Academy of Neurology (AAN). Since the AAN published guidelines for migraine prevention in 2000, new clinical studies have addressed and readdressed the efficacy and safety of migraine preventive therapies.The short slide show above reviews guideline-endorsed pharmacotherapy for migraine prevention, behavioral interventions, and new research on difficult comorbid conditions.Â
Related Videos
